此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Comparison of Walking in Water and on Land in People With Chronic Obstructive Pulmonary Disease (COPD)

2021年8月19日 更新者:Renae McNamara、European Respiratory Society

Determining the Metabolic Load of Walking in Water Compared to Walking on Land in People With COPD, Who Are Normal Weight and Obese, Compared to Peak Exercise Metabolic Response: a Prospective, Randomised Cross-over Pilot Trial

The purpose of this study is to evaluate the metabolic load during a single session of moderate intensity walking in water compared to walking on land (over-ground) in people with chronic obstructive pulmonary disease (COPD) who are normal weight and obese, compared with peak exercise metabolic response.

The hypothesis is that the metabolic load of walking at a moderate intensity in water will be greater than walking on land.

研究概览

研究类型

介入性

注册 (实际的)

14

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

      • Horn、荷兰
        • Centre of intergrated rehabilitation for chronic organ failure

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

18年 及以上 (成人、年长者)

接受健康志愿者

有资格学习的性别

全部

描述

Inclusion Criteria:

  • diagnosis of COPD (FEV1/FVC <0.7) in a clinically stable state (no acute exacerbation of COPD within the previous 4 weeks)
  • accepting of walking in water
  • BMI >/= 21 kg/m2

Exclusion Criteria:

  • long-term oxygen therapy
  • contraindications to entering a hydrotherapy pool

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:治疗
  • 分配:随机化
  • 介入模型:交叉作业
  • 屏蔽:无(打开标签)

武器和干预

参与者组/臂
干预/治疗
实验性的:COPD (normal weight)
People with COPD (BMI 21 kg/m2 to 29 kg/m2)

Participants will walk in the water for 15 minutes at an intensity rating of five on the modified Borg scale for dyspnoea or perceived exertion, whichever is the highest. Walking intensity will be measured every three minutes during each walking session. If the intensity level is reported as below five, participants will be encouraged to increase the intensity by increasing their walking speed.

During walking in water, VO2 and VE will be measured breath-by-breath using the Oxycon mobile. Every three minutes during the walking, heart rate, oxygen saturation, dyspnoea and exertion will be measured.

Participants will walk on land for 15 minutes at an intensity rating of five on the modified Borg scale for dyspnoea or perceived exertion, whichever is the highest. Walking intensity will be measured every three minutes during each walking session. If the intensity level is reported as below five, participants will be encouraged to increase the intensity by increasing their walking speed.

During walking on land, VO2 and VE will be measured breath-by-breath using the Oxycon mobile. Every three minutes during the walking, heart rate, oxygen saturation, dyspnoea and exertion will be measured.

实验性的:COPD (obese)
People with COPD (BMI >/= 30 kg/m2)

Participants will walk in the water for 15 minutes at an intensity rating of five on the modified Borg scale for dyspnoea or perceived exertion, whichever is the highest. Walking intensity will be measured every three minutes during each walking session. If the intensity level is reported as below five, participants will be encouraged to increase the intensity by increasing their walking speed.

During walking in water, VO2 and VE will be measured breath-by-breath using the Oxycon mobile. Every three minutes during the walking, heart rate, oxygen saturation, dyspnoea and exertion will be measured.

Participants will walk on land for 15 minutes at an intensity rating of five on the modified Borg scale for dyspnoea or perceived exertion, whichever is the highest. Walking intensity will be measured every three minutes during each walking session. If the intensity level is reported as below five, participants will be encouraged to increase the intensity by increasing their walking speed.

During walking on land, VO2 and VE will be measured breath-by-breath using the Oxycon mobile. Every three minutes during the walking, heart rate, oxygen saturation, dyspnoea and exertion will be measured.

研究衡量的是什么?

主要结果指标

结果测量
大体时间
Breath-by-breath oxygen consumption (VO2)
大体时间:Day of assessment during study measurement period (15 minutes)
Day of assessment during study measurement period (15 minutes)

次要结果测量

结果测量
大体时间
Minute ventilation (VE)
大体时间:Day of assessment during study measurement period (15 minutes)
Day of assessment during study measurement period (15 minutes)

其他结果措施

结果测量
大体时间
Dyspnoea, measured by the modified Borg 0-10 category ratio scale
大体时间:Day of assessment during study measurement period (15 minutes)
Day of assessment during study measurement period (15 minutes)
Exertion, measured by the modified Borg 0-10 category ratio scale
大体时间:Day of assessment during study measurement period (15 minutes)
Day of assessment during study measurement period (15 minutes)
Oxygen saturation
大体时间:Day of assessment during study measurement period (15 minutes)
Day of assessment during study measurement period (15 minutes)
Heart rate
大体时间:Day of assessment during study measurement period (15 minutes)
Day of assessment during study measurement period (15 minutes)

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 研究主任:Martijn A Spruit, PhD、Centre of integrated rehabilitation for chronic organ failure

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始

2016年10月1日

初级完成 (实际的)

2020年1月1日

研究完成 (实际的)

2020年1月1日

研究注册日期

首次提交

2016年4月7日

首先提交符合 QC 标准的

2016年4月27日

首次发布 (估计)

2016年4月29日

研究记录更新

最后更新发布 (实际的)

2021年8月25日

上次提交的符合 QC 标准的更新

2021年8月19日

最后验证

2021年8月1日

更多信息

与本研究相关的术语

关键字

其他研究编号

  • ERS STRTF 2015 - 9368

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

Water-based walking的临床试验

3
订阅